MOLECULAR BIOMARKER FOR DIAGNOSIS OF COMMUNITY-ACQUIRED PNEUMONIA ON INTENSIVE CARE UNIT ADMISSION

摘要

The invention relates to a method for diagnosing whether a patient is at risk of suffering from community acquired pneumonia (CAP) comprising steps of: (a) determining the expression levels of FAIM3 and PLAC8 in a biological sample of said patient; (b) comparing said expression levels with a reference control, and (c) determining the risk of suffering from CAP based on said expression levels. In a preferred embodiment, said step a comprises determining the ratio of the expression levels of FAIM3 and PLAC8, and step b comprises determining said risk based on said ratio.